Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOptiBiotix Health Regulatory News (OPTI)

Share Price Information for OptiBiotix Health (OPTI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.00
Bid: 17.50
Ask: 18.50
Change: 0.50 (2.86%)
Spread: 1.00 (5.714%)
Open: 17.50
High: 18.00
Low: 17.50
Prev. Close: 17.50
OPTI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Final Results

28 Oct 2011 07:00

CERES MEDIA INTERNATIONAL PLC ("Ceres" or the "Company" or the "Group") Final Results to 31 July 2011

CHAIRMAN'S STATEMENT

I am pleased to present shareholders with the Report and Accounts for the year to 31 July 2011. In my last statement made on 28 April 2011 reporting on the 6 months activities to 31 January 2011 for Hartfield Securities PLC (as the company was then called) I advised shareholders of the board's intention to acquire Ceres Media PLC, a company that had developed natural sustainable environmental advertising and marketing products for companies seeking to promote their products, brands and corporate social responsibility through the use of natural materials.

On 17 March 2011 the Company made a recommended offer for the entire issued share capital of Ceres Media PLC which was declared unconditional in all respects and Ceres Media PLC ultimately became a wholly owned subsidiary of the Company (the "Acquisition"). Ceres Media PLC is the holding company for its wholly-owned subsidiary Natural AdCampaign whose products include advertising, promotional and public relations products as well as a full selection of printed products using its patent-pending NatureWovenTM range of digitally printable materials.

On 9 May 2011 the Company withdrew its listing to trading on PLUS Markets and changed its name from Hartfield Securities PLC to Ceres Media International PLC.

For the period to 31 July 2011 the Group recorded revenues of £30k.

PLACING AND ADMISSION TO AIM

On 9 September 2011 the Company raised £1m by way of a placing of 5,555,556 new ordinary shares and was admitted to trading on AIM ("Admission").

DIRECTORATE CHANGES

On 9 May 2011, following the Acquisition, Gerald Raingold, Malcolm Coleman and Brian Leader-Cramer stepped down from the board. I would like to thank them for their hard work and efforts over the last number of years. Also on 9 May 2011 Alex Dowdeswell was appointed as Chief Executive Officer, Matthew Howes as Finance Director and Leslie Barber as a Non-executive Director. I would like to welcome them to the board.

UPDATE

Since Admission Ceres Media has continued to invest in product development, intellectual property protection and commercialisation of its products and continues to work on expanding its sales and marketing and improving quality control with its manufacturing partners.

Work has been ongoing with the expansion of the distributor network within the United Kingdom, the United States of America and Europe.

The NatureWovenTM range of products includes:-

"Chorus", a jute based material with a natural look and feel that enhances the credentials of the printed branding, and

"Gossyp", a cotton based fabric which provides fine print detail, enabling images to look very similar to how they appear when printed on PVC.

Both Chorus and Gossyp are stocked across a number of international territories and are being used in a number of different areas within the display market. Ceres Media is focussing on increasing awareness of its products in its target markets and has accordingly strengthened its sales force. Whilst sales levels have been modest to date they will continue to improve as Ceres Media benefits from better market awareness, new sales territories and the additional products being available to the market.

The board has noted that the demand for Chorus and Gossyp has varied according to geographic market. The board is refocusing it sales and marketing strategy in certain markets on end-users to "pull" demand for the product rather than the more traditional method of targeting printers and distributors to "push" demand. The board is hopeful this refocusing will lead to a faster take-up of Chorus and Gossyp product across all market sectors, which to date has been slower than anticipated.

Ceres Media's TierraFilmTM product, "window film" is due to be available in the United Kingdom market in November 2011 in commercial volumes. Certain key distributors and printers have already been trialling test batches with positive feedback.

Ceres Media originally projected that TierraFilmTM would be commercially available in the United Kingdom in early October 2011, however, it has experienced a delay in delivering the TierraFilmTM window film into the market due to a product refinement to more fully meet end users expectations.

This delay has pushed back the anticipated sales by 2 -3 months, however the board remains hopeful that the Company will meet its sales budget in the current year.

I would like to thank my colleagues on the board, our employees and distributors, for all the hard work during the last year, and look forward to reporting further progress in the months ahead.

Norman Fetterman

Chairman

Consolidated Statement of Comprehensive Income for the period 1 March 2011 to31 July 2011 Period 1 March Period 1 March 2011 to 31 July 2011 to 28 2011 February 2011 £ As restated £ CONTINUING OPERATIONS Revenue 30,054 2,342 Cost of sales (37,688) - Administrative expenses (472,532) (258,752) OPERATING LOSS (480,166) (256,410) Interest income 250 - Finance costs (4,859) - LOSS BEFORE INCOME TAX (484,775) (256,410) Income tax - - TOTAL COMPREHENSIVE EXPENSE FOR (484,775) (256,410)THE YEAR LOSS PER SHARE BASIC AND DILUTED LOSS PER SHARE 0.021 0.013

The comparatives are noted as restated as they relate to Ceres Media Plc. See Principal Accounting Policies for further details.

All of the activities of the Group are classed as continuing.

31 July 2011 28 February 2011 £ (as restated) £ ASSETS NON-CURRENT ASSETS Goodwill 868,088 129,442 Intangible assets 223,306 217,800 Property, plant and equipment 9,057 3,440 Investments - - Trade and other receivables - 10,000 1,100,451 360,682 CURRENT ASSETS Inventories 162,663 48,193 Trade and other receivables 98,313 51,607 Cash and cash equivalents 55,911 13,528 316,887 113,328 TOTAL ASSETS 1,417,338 474,010 EQUITY SHAREHOLDERS' EQUITY Called up share capital 5,200,348 150,539 Share premium - 419,249 Other reserves (3,444,552) - Retained earnings (875,172) (390,397) TOTAL EQUITY 880,624 179,391 LIABILITIES CURRENT LIABILITIES Trade and other payables 536,714 199,944 Financial liabilities: borrowings Interest bearing loans and borrowings - 94,675 TOTAL LIABILITIES 536,714 294,619 TOTAL EQUITY AND LIABILITIES 1,417,338 474,010

Consolidated Statement of Financial position for the period 1 March 2011 to 31 July 2011

Consolidated Statement of Cash Flows fir the period 1 March 2011 to 31 July2011 Period to Period to 31 July 28 February 2011 2011 £ As restated £ Cash flows from operating activities Loss before income tax (484,775) (256,410) Depreciation charges 1,304 1,616 Investment income (250) - Increase in inventories (114,470) (48,193) Increase in trade and other receivables 50,144 (50,424) Increase in trade and other payables 229,629 158,259 Costs settled by issue of shares - - Net cash from operating activities (318,418) (195,152) Cash flows from investing activities (28,006) (75,181) Purchase of intangible fixed assets Purchase of tangible fixed assets (6,921) (826) Acquisition of subsidiaries, net of cash 385,144 - Finance income received 250 - Movement in balances with other Group companies - - Net cash from investing activities 350,467 (76,007) Cash flows from financing activities New loans in year - 94,675 Amount withdrawn by directors - (22,086) Share issue 10,334 219,866 Net cash from financing activities 10,334 292,455 Increase/(Decrease) in cash and cash 42,383 21,296equivalents Cash and cash equivalents at beginning of 13,528 (7,768)period Cash and cash equivalents at end of period 55,911 13,528

CASH AND CASH EQUIVALENTS

The amounts disclosed on the statement of cash flow in respect of cash and cash equivalents are in respect of these statement of financial position amounts:

31 July 2011 28 February 2011 £ As restated £ Cash and cash equivalents 55,911 13,528 Bank overdrafts - - Notes:1 ACCOUNTING POLICIESBasis of preparation

These financial statements have been prepared in accordance with International Financial Reporting Standards and IFRIC interpretations and with those parts of the Companies Act 2006 applicable to companies reporting under IFRS. The financial statements have been prepared under the historical cost convention.

The preparation of financial statements in conformity with generally accepted accounting principles requires the use of estimates and assumptions that effect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Although these estimates are based on management's best knowledge of the amount, actual results may differ from those of estimates.

The principal accounting policies are summarised below. They have all been applied consistently throughout the period under review.

Standards, amendments and interpretations effective in 2011 but not relevant

The following new standards, amendments and interpretations to published standards are mandatory for accounting periods beginning on or after 1 February 2011 but are not relevant to the company's operations:

* IFRIC 17 Distribution of Non Cash Assets to Owners * IFRIC 19 Transfers of Assets from Customers * IFRS 3 (revised) Business Combinations * IAS 27 (amended) Consolidated and Separate Financial Statements * IFRS 1 (revised) First Time Adoption of IFRS * IFRS 1 and IAS 27 (amendments) Cost of an Investment in a Subsidiary, Jointly Controlled Equity or Associate * IAS 39 (amendment) Financial Instruments- Recognition and Measurement: Eligible Hedged Items * IFRIC 9 and IAS 39 (amendment) Embedded Derivatives * IFRS 1 (amendment) Additional exemptions for first time adopters * IFRS 2 Group cash settled share based payment transactions * Improvements to IFRS's (issued April 2009)

Standards, amendments and interpretations to existing standards that are not yet effective and have not been early adopted by the Ceres Media Group

The following standards, amendments and interpretation to existing standards were in issue at the date of authorisation of these financial statements, but are not yet effective, and in some cases have not been adopted by the EU:

* IFRIC 19 Extinguished Financial Liabilities with Equity Instruments * IFRIC 14 (amendment) Prepayment of minimum funding requirement * IFRS 1 (amendment) Limited exemption from comparative IFRS 7 disclosure for first-time adopters * IAS 32 (amendment) Financial instruments: Presentation: clarification of rights issue * IAS 24 (revised) Related Party Disclosures * IFRS 9 Financial Instruments * IFRS 7 (amendment) Financial Instruments Disclosures * Improvements to IFRS (issued May 2010) * IAS 12 (amendment) Deferred tax: Recovery of Underlying Assets * IFRS 1 (amendment) Severe Hyperinflation and removal of fixed dates for first-time adopters

The directors of Ceres Media do not anticipate any material impact on the company's financial statements when the standards and interpretations become effective.

Basis of consolidation

The Group financial statements consolidate the financial statements of the Company and all of its subsidiaries.

On 9 May 2011, Ceres Media International Plc (formerly Hartfield Securities Plc) became the legal parent of Ceres Media Plc in a share-for-share exchange. In accordance with IFRS 3 `Business combinations', this transaction has been accounted for as a reverse acquisition, such that in substance, Ceres Media Plc has acquired Ceres Media International Plc. Accordingly, the comparative information for Ceres Media Plc has been presented for the period ended 28 February 2011 and these financial statements present a continuation of the business of Ceres Media Plc as the legal subsidiary.

Going concern

Since the balance sheet date the Ceres Media Plc group has been funded by Ceres Media International Plc, a Company incorporated in England and Wales. The directors anticipated that support will continue on this basis consider it appropriate to prepare the financial statements on the going concern basis. The financial statements do not include any adjustments that would result from withdrawal of support.

Revenue recognition

Revenue represents amounts receivable for goods and services net of VAT and trade discounts.

Revenue is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer and the amount of revenue can be measured reliably.

Investments

Investments in subsidiaries are held at cost less any impairment.

Intangible assets

An intangible asset, which is an identifiable non-monetary asset without physical substance, is recognised to the extent that it is probable that the expected future economic benefits attributable to the asset will flow to the Group and that its cost can be reliably measured. The asset is deemed to be identifiable when it is separable or when it arises from contractual or legal rights.

Goodwill

Goodwill represents any excess of the cost of acquisition over the fair value of the identifiable assets and liabilities acquired. Goodwill is tested annually for impairment and is earned at cost less accumulated impairment losses.

Property, plant and equipment

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Plant and machinery - 25% on cost

Financial instruments

Financial assets and liabilities are recognised at fair value in the Group's balance sheet when the Group becomes a party to the contractual provisions of the instrument.

The Group classifies its financial instruments into loans and receivables (comprising cash and trade receivables) and other liabilities (comprising trade payables).

Inventories

Inventories are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items

Trade and other receivables

Trade and other receivables do not carry any interest and are stated at their nominal value unadjusted to reflect discounting for the time value of cash flows recoverable and are reduced by appropriate allowances for estimated irrecoverable amounts.

Cash and cash equivalents

Cash and cash equivalents comprise cash in hand and deposits which are readily convertible to known amounts of cash and which are subject to insignificant risk of changes in value and have an original maturity of three months or less at acquisition. Bank overdrafts are included within current liabilities unless there is a right of offset with cash balances.

Financial liabilities and equity

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the group after deducting all of its liabilities.

Trade and other payables

Trade payables are not interest bearing and are stated at their carrying value.

Capital Management

Capital is made up of stated capital, premium and retained earnings. The objective of the Company's capital management is to ensure that it maintains strong credit ratings and capital ratios. This will ensure that the business is correctly supported and shareholder value is maximised.

The Company manages its capital structure through adjustments that are dependent on economic conditions. In order to maintain or adjust the capital structure, the Company may choose to change or amend dividend payments to shareholders or issue new share capital to shareholders. There were no changes to the objectives, policies or processes during the period ended 31 July 2011.

Equity instruments

Equity instruments issued by the group are recorded at the proceeds received, net of direct issue costs.

Taxation

Current taxes are based on the results shown in the financial statements and are calculated according to local tax rules, using tax rates enacted or substantially enacted by the balance sheet date.

Research and development

Expenditure incurred in the development of products or enhancements to existing products, and their related intellectual property rights, is capitalised as an intangible asset only when the future economic benefits expected to arise are deemed probable and the costs can be reliably measured. Development costs not meeting these criteria are charged as costs within the Comprehensive Statement of Income.

Foreign currencies

Monetary assets and liabilities denominated in foreign currencies are translated into sterling at the rate of exchange ruling at the balance sheet date. Transactions in foreign currencies are recorded at the rate ruling at the date of the transaction. All differences are taken to the Comprehensive Statement of Income.

Deferred taxation

Deferred taxation is provided in full in respect of taxation deferred by timing differences between the treatment of certain items for taxation and accountancy purposes. The deferred tax balance has not been discounted.

Critical accounting judgements

The preparation of the financial statements under IFRS requires the Company to make estimates and assumptions that affect the application of policies and reported amounts. Estimates and judgements are continually evaluated and are based on historical experience and other factors including expectations of future events that are believed to be reasonable under the circumstances. Actual results may differ from these estimates.

Financial risk management

The Group is exposed through its operations to one or more of the following financial risks that arise from its use of financial instruments. A risk management programme has been established to protect the Group against the potential adverse effects of these financial risks.

Credit risk

The Group has Trade receivables at 31 July 2011 £35,397. This balance is reviewed regularly to minimise any credit risk.

Liquidity risk

Liquidity risk arises from the Group's management of working capital and finance charges. It is the risk that the Group will encounter difficulty in meeting its financial obligations as they fall due. The liquidity risk is managed centrally by the finance function. Budgets are set and are agreed by the Board. As at 31 July 2011, the Group had cash and cash equivalents amounting to £55,911.

Interest rate risk

The Group not exposed to interest rate risk.

Foreign currency risk

The Group transacts in US dollars and is exposed to foreign currency risk in respect of these transactions. Currently the group does not make use of hedging instruments. The Board monitors the exposure of the Group to foreign currency risks and will consider on an ongoing basis the implementation of hedging procedures.

2 LOSS PER SHARE

The calculation of basic loss per share is based on the loss attributable to ordinary shareholders and the weighted average number of ordinary shares in issue during the period.

The calculation of diluted loss per share is based on loss per share attributable to ordinary shareholders and the weighted average number of ordinary shares that would be in issue, assuming conversion of all dilutive potential ordinary shares into ordinary shares.

Reconciliations of the loss and weighted average number of shares used in the calculations are set out below:

Period to Period to 31 July 28 February 2011 2011 £ £ Basic loss per share Reported loss (484,775) (256,410) Reported loss per share 0.021 0.013 Weighted average number of ordinary shares: Shares issued in respect of the 20,212,492 20,212,492acquisition of Ceres Media plc Effect of reverse acquisition of Ceres 3,161,234 -Media International plc Weighted average number of shares 23,373,726 20,212,492

Due to the Group's loss for the period, the diluted loss per share is the same as the basic loss per share.

3 POSTING OF ACCOUNTS

Copies of the Report and Accounts for the period ended 31 July 2011 will be sent to shareholders on 31 October 2011 and will be available from the company's website www.ceresmediaplc.com.

4 ANNUAL GENERAL MEETING

Included in the Report and Accounts is a Notice of Annual General Meeting, which has been convened for Monday 19 December 2011 at 11:00 a.m. at the offices of Davies Arnold Cooper, 6-8 Bouverie Street, London EC4Y 8DD.

For further information, please contact:

Ceres Media International PLC Tel: 020 3178 5622 Alex Dowdeswell CEO Nominated Adviser Tel: 020 7148 7900 Cairn Financial Advisers LLP Jo Turner / Liam Murray Broker Tel: 020 3002 2070 First Columbus LLP Chris Crawford / Kelly Gardiner Financial PR Tel: 020 7556 1063 De Facto Financial

Mike Wort / Anna Dunphy

XLON
Date   Source Headline
10th May 20247:00 amRNSInvestor update
30th Apr 20247:00 amRNSManufacturing agreement with KAG Industries
15th Apr 20248:49 amRNSHolding(s) in Company
25th Mar 20247:00 amRNSPlacing, Subscription and Director Dealing
18th Mar 202411:36 amRNSHolding(s) in Company
13th Mar 20247:00 amRNSPartnership agreement with Morepen for SlimBiome
8th Mar 20244:09 pmRNSHolding(s) in Company
27th Feb 20247:00 amRNSStrategic and commercial update
9th Feb 20247:00 amRNSChange of auditor
5th Feb 20247:00 amRNSPresentation at ProBiota 2024
30th Jan 20247:00 amRNSSweetBiotix Update
15th Jan 20247:00 amRNSLaunch of LeanBiome in Muscletech
4th Dec 20237:00 amRNSDirectorate Change
28th Nov 20237:00 amRNSDistribution agreement for SlimBiome
24th Nov 20237:00 amRNSHolding(s) in Company
22nd Nov 20237:00 amRNSBBSRC Grant for WellBiome®
1st Nov 20237:00 amRNSCommercial update
23rd Oct 20237:00 amRNSLicense agreement with Tata Chemicals
19th Oct 20233:02 pmRNSHolding(s) in Company
27th Sep 20237:00 amRNSHalf-year Report
22nd Sep 20237:00 amRNSPlanned launch of OptiBiotix products with Boots
29th Aug 20237:00 amRNSCommercial update
31st Jul 202312:51 pmRNSHolding(s) in Company
26th Jul 202312:34 pmRNSResult of AGM
19th Jul 20237:00 amRNSSweetBiotix® overview
28th Jun 20237:00 amRNSFinal Results
4th May 20237:00 amRNSInvestor update
21st Mar 20237:00 amRNSChange of Broker
15th Mar 20237:00 amRNSSlimbiome study results
21st Feb 20237:00 amRNSDirectorate Change
30th Jan 20234:28 pmRNSHolding(s) in Company
5th Dec 20227:00 amRNSIssue of Equity – Subscription
10th Nov 202211:30 amRNSInvestor update
1st Nov 20227:00 amRNSLaunch of GoFigure products on Tmall China
24th Oct 20227:00 amRNSApproval of GoFigure products
17th Oct 20227:00 amRNSNew health claims for SlimBiome in Australia
17th Oct 20227:00 amRNSNew health claims for SlimBiome in Australia
28th Sep 20227:00 amRNSHalf-year Report
26th Sep 20227:00 amRNSLaunch of novel prebiotic in Europe and Africa
20th Sep 20227:00 amRNSLaunch of GoFigure range with Apollo Hospitals
14th Sep 20227:00 amRNSNew commercialisation partner in Asia Pacific
24th Aug 20224:41 pmRNSSecond Price Monitoring Extn
24th Aug 20224:35 pmRNSPrice Monitoring Extension
24th Aug 20222:06 pmRNSSecond Price Monitoring Extn
24th Aug 20222:00 pmRNSPrice Monitoring Extension
24th Aug 202211:06 amRNSSecond Price Monitoring Extn
24th Aug 202211:00 amRNSPrice Monitoring Extension
24th Aug 20229:05 amRNSSecond Price Monitoring Extn
24th Aug 20229:00 amRNSPrice Monitoring Extension
24th Aug 20227:00 amRNSTrading update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.